Anna Vavra Sutherland, MD | |
609 Albany St, Boston, MA 02118-2515 | |
(617) 358-9700 | |
Not Available |
Full Name | Anna Vavra Sutherland |
---|---|
Gender | Female |
Speciality | Student In An Organized Health Care Education/training Program |
Location | 609 Albany St, Boston, Massachusetts |
Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
Identifier | Type | State | Issuer |
---|---|---|---|
1881222388 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207N00000X | Dermatology | 289491 (Massachusetts) | Secondary |
390200000X | Student In An Organized Health Care Education/training Program | (* (Not Available)) | Primary |
Mailing Address | Practice Location Address |
---|---|
Anna Vavra Sutherland, MD 609 Albany St, Boston, MA 02118-2515 Ph: () - | Anna Vavra Sutherland, MD 609 Albany St, Boston, MA 02118-2515 Ph: (617) 358-9700 |
News Archive
Diaphragmatic pacing in conjunction with non-invasive ventilation is detrimental to patients with amyotrophic lateral sclerosis and respiratory insufficiency, show findings from a randomised controlled trial.
A new study is expected to provide the first detailed information on how infectious diseases may be transmitted aboard commercial airliners. Sponsored by aircraft manufacturer Boeing, the research will document patterns of passenger movement inside aircraft cabins and inventory the microbes present in cabin air and on surfaces such as tray tables and lavatory fixtures.
A new study published today in the journal Clinical Oral Investigations, has found that sugar-sweetened acidic drinks, such as soft drinks, is the common factor between obesity and tooth wear among adults.
Keystone Symposia on Molecular and Cellular Biology is pleased to announce receipt of a $1.37 million, five-year MARC (Minority Access to Research Careers) Ancillary Training Activities grant from the National Institute of General Medical Sciences of the National Institutes of Health (NIH).
In the worldwide effort to battle SARS-CoV-2, the virus that causes COVID-19, researchers have often turned to medications used as therapies for other conditions in the hopes of finding ones that either kill the coronavirus or lessen the impacts from its infection.
› Verified 2 days ago